<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9130">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05704673</url>
  </required_header>
  <id_info>
    <org_study_id>17101956</org_study_id>
    <nct_id>NCT05704673</nct_id>
  </id_info>
  <brief_title>Effect of IV Nalbuphine on Nausea and Vomiting Following Intrathecal Morphine</brief_title>
  <official_title>Effect of IV Nalbuphine on Postoperative Nausea and Vomiting Following Intrathecal Morphine in Patients Undergoing Inguinal Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the study aimed to investigate the effect of Iv nalbuphine on postoperative nausea and&#xD;
      vomiting and pain with intrathecal morphine on inguinal hernia repair surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bupivacaine hydrochloride is a commonly used local anesthetic in spinal anesthesia, however,&#xD;
      the duration of spinal analgesia by bupivacaine is limited to about 75- 150 minutes.2&#xD;
      Therefore, various additives have been used with bupivacaine to prolong its effects and&#xD;
      improve the quality of analgesia.(1) Opioids are the most popular used adjuvants added to&#xD;
      bupivacaine in spinal blockade to obtain a sufficient intraoperative visceral analgesia and&#xD;
      increase the duration and quality of postoperative analgesia, with less sympathetic block and&#xD;
      hemodynamic effect .(2) morphine is commonly used for analgesia, but is frequently associated&#xD;
      with postoperative nausea and vomiting (PONV) and pruritus, These side effects may lead to&#xD;
      patient discomfort and prolonged hospital stay thus limiting the usefulness of IT morphine.&#xD;
&#xD;
      Nalbuphine is a mu receptor antagonist and a Ä¸appa receptor agonist.10 When added as an&#xD;
      adjunct to intrathecal local anesthetics, it provides good analgesia with decreased incidence&#xD;
      and severity of mu receptor side effects(3) Morphine binds most readily to the mu-opioid&#xD;
      receptor and less well to the kappa-opioid receptor. So, the undesirable adverse events of&#xD;
      morphine are thought to result from agonism at the mu-opioid receptor.5 Many drugs have been&#xD;
      tried with morphine to potentiate its analgesic effects or to reduce the adverse events.6&#xD;
      Nalbuphine is a mixed opioid agonist-antagonist that acts mainly through kappa-opioid&#xD;
      receptors, and it may attenuate mu-opioid receptor related side effects.3 Moreover, recent&#xD;
      studies suggested that the analgesic effects of morphine and nalbuphine may be additive.&#xD;
&#xD;
      The addition of nalbuphine to intrathecal bupivacaine plus morphine significantly reduced the&#xD;
      incidence and severity of postoperative nausea and vomiting and pruritus without affecting&#xD;
      analgesic potency..(4)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2023</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of IV nalbuphine on postoperative nausea and vomiting following intrathecal morphine in patients undergoing inguinal hernia repair</measure>
    <time_frame>1. a. Primary (main): postoperative nausea and vomiting [ Time Frame: 24 hours ] A verbal descriptive scale (VDS) was used to assess the severity of PONV. ( no nausea=0, severe nausea= 3 by postoperative nausea and vomiting scale which range (o no nasuea</time_frame>
    <description>investigate the effect of Iv nalbuphine on postoperative nausea and vomiting and pain with intrathecal morphine on inguinal hernia repair surgery.&#xD;
A verbal descriptive scale (VDS) was used to assess the severity of PONV. ( no nausea=0, severe nausea= 3 by postoperative nausea and vomiting scale which range (o no nasuea to 3 sever vomating).&#xD;
A verbal descriptive scale (VDS) was used to assess the severity of PONV b. Secondary (subsidiary): postoperative pain and puririts. [ Time Frame: 24 hours ] c. Visual analogue scale (VAS) pain scores (no pain = 0, worst possible pain = 3).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Inguinal Hernia</condition>
  <arm_group>
    <arm_group_label>group (1)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>who given intrathecal morphine thin IV nalbuphine and asize of 80 patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group (2)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>who given intrathecal morphine onInguinal hernia druing spinal anathesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nalbuphine on N and V and pain with intrathecal morphine onInguinal hernia repair surgery. randomized, prospective, double blinded and placebo-controlled trial study.</intervention_name>
    <description>investigate the effect of Iv nalbuphine on postoperative nausea and vomiting and pain with intrathecal morphine on inguinal hernia repair surgery.</description>
    <arm_group_label>group (1)</arm_group_label>
    <arm_group_label>group (2)</arm_group_label>
    <other_name>nalbuphine</other_name>
    <other_name>intrathecal morphine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients of aged 15-70years old&#xD;
&#xD;
          -  males&#xD;
&#xD;
          -  Scheduled patients for inguinal hernia repair surgery with under spinal anesthesia.&#xD;
&#xD;
          -  ASA grade 1,2&#xD;
&#xD;
          -  normal cardiac and renal function&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal&#xD;
&#xD;
          -  Allergy to the studied drugs.&#xD;
&#xD;
          -  Patients with contraindications to spinal anesthesia&#xD;
&#xD;
          -  ASA grade 3,4&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>males</gender_description>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rehab Marzouk, master</last_name>
    <phone>01022290058</phone>
    <email>e01022290058@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Prof. Fatma Asker, Professor</last_name>
    <phone>01005803969</phone>
    <email>F.askar@aun.edu.eg</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Ibrahim AS, Aly MG, Thabet ME, Abdelaziz MR. Effect of adding nalbuphine to intrathecal bupivacaine with morphine on postoperative nausea and vomiting and pruritus after elective cesarean delivery: a randomized double blinded study. Minerva Anestesiol. 2019 Mar;85(3):255-262. doi: 10.23736/S0375-9393.18.12751-9. Epub 2018 May 30.</citation>
    <PMID>29856176</PMID>
  </results_reference>
  <verification_date>May 2023</verification_date>
  <study_first_submitted>January 20, 2023</study_first_submitted>
  <study_first_submitted_qc>January 20, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2023</study_first_posted>
  <last_update_submitted>May 5, 2023</last_update_submitted>
  <last_update_submitted_qc>May 5, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Rehab Marzouk Gomaa</investigator_full_name>
    <investigator_title>house officer</investigator_title>
  </responsible_party>
  <keyword>nalbuphine</keyword>
  <keyword>morphine</keyword>
  <keyword>IV</keyword>
  <keyword>Intrathecal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Nalbuphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

